Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 perturbation on US air quality and human health impact assessment.
He J, Harkins C, O'Dell K, Li M, Francoeur C, Aikin KC, Anenberg S, Baker B, Brown SS, Coggon MM, Frost GJ, Gilman JB, Kondragunta S, Lamplugh A, Lyu C, Moon Z, Pierce BR, Schwantes RH, Stockwell CE, Warneke C, Yang K, Nowlan CR, González Abad G, McDonald BC. He J, et al. PNAS Nexus. 2024 Jan 2;3(1):pgad483. doi: 10.1093/pnasnexus/pgad483. eCollection 2024 Jan. PNAS Nexus. 2024. PMID: 38222466 Free PMC article.
Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study.
Zhang Q, Ouyang Q, Li W, Chiu J, Yan M, Lu YS, Sun S, Li H, Du Y, Wang X, Sun T, Yin Y, Wang H, Ye F, Shen K, Wang J, Pan Y, Wang S, Yang J, Wu X, Dai MS, Cheng J, Teng Y, Su F, Wu X, He J, Fu P, Yang L, Xin Y, Wang X, Jiang Z. Zhang Q, et al. Among authors: he j. Transl Breast Cancer Res. 2022 Oct 31;3:31. doi: 10.21037/tbcr-22-35. eCollection 2022. Transl Breast Cancer Res. 2022. PMID: 38751523 Free PMC article.
Reactive Oxygen Species-Responsive Delivery of a Notch Inhibitor to Alleviate Nonalcoholic Steatohepatitis by Inhibiting Hepatic de Novo Lipogenesis and Inflammation.
Chen J, Zhang J, Xia Y, Li J, Jia Q, Zhang Z, Jing X, Xu Y, Zou L, Wang L, Song H, Li J, Liu Q, Xiong Y, Tang Q, Chen W, Yang N, Xu H, Li Y, He J. Chen J, et al. Among authors: he j. Mol Pharm. 2024 May 15. doi: 10.1021/acs.molpharmaceut.4c00070. Online ahead of print. Mol Pharm. 2024. PMID: 38751169
32,152 results
You have reached the last available page of results. Please see the User Guide for more information.